Trajectory and genetic correlation mapping of cross-disease risks following incident type 2 inflammatory diseases
Abstract
Background: Type 2 inflammatory diseases (T2IDs) such as atopic dermatitis (AD), asthma, food allergy, eosinophilic esophagitis (EoE), chronic sinusitis (CS), and others, are immune-mediated conditions that frequently co-occur across organ systems and contribute to substantial disease burden. While the atopic march has long served as a conceptual model for T2ID progression, it remains unclear whether this linear sequence captures the broader comorbidity structure of T2IDs.
Methods: We systematically analyzed comorbidity patterns across nine T2IDs using two complementary methods: Large-scale real-world data (RWD) from over 129 million electronic health records, genome-wide and local genetic correlation, including three novel (asthma, chronic sinusitis, allergic rhinitis) metanalyses of genome-wide association studies.
Results: Retrospective matched cohort analyses reveal a highly interconnected disease network in which CS emerged as a central node, increasing the risk of multiple other T2IDs across diverse patient populations. AD, food allergy, and vasomotor and allergic rhinitis also show strong cross-disease effects. Subgroup analyses uncover notable age-, sex-, and race-specific disparities. Genetic correlation analyses support shared heritability among many disease pairs, complemented by the temporal ordering of associations present in the RWD. Local genetic correlation position asthma as the central node of the shared polygenic architecture, converging on canonical type 2 inflammatory loci.
Conclusions: Together, our results highlight that T2ID progression extends beyond the atopic march and is shaped by a complex and heterogeneous network of interactions. This work provides a data-driven framework to guide risk stratification, inform early preventive strategies, and prioritize upstream disease targets within the type 2 inflammatory spectrum.
Related
- Composite inflammatory indices and incident lung cancer risk in an exploratory statistical mediation analysis
- Inflammatory Burden, Structural Exposure, and Racial Disparities in Incident Heart Failure: Evidence from the Multi-Ethnic Study of Atherosclerosis
- Exposure to ambient benzene, genetic susceptibility, and incident rheumatic diseases in the UK
- Joint Association of Parity and Spontaneous Miscarriage with Incident Cardiovascular Diseases
- Correlation between myeloproliferative diseases and T cell acute lymphoblastic leukemia: a case report and literature review.
BibTeX
@article{gupta2026trajectory,
title = {{Trajectory and genetic correlation mapping of cross-disease risks following incident type 2 inflammatory diseases}},
author = {Yask Gupta and Henning Olbrich and Diamant Thaci and Katja Bieber and Philip Curman and Ralf J. Ludwig},
journal = {Communications Medicine},
year = {2026},
month = nov,
doi = {10.1038/s43856-026-02000-y},
url = {https://www.nature.com/articles/s43856-026-02000-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Trajectory and genetic correlation mapping of cross-disease risks following incident type 2 inflammatory diseases
AU - Yask Gupta
AU - Henning Olbrich
AU - Diamant Thaci
AU - Katja Bieber
AU - Philip Curman
AU - Ralf J. Ludwig
PY - 2026
DA - 2026/11/06
JO - Communications Medicine
DO - 10.1038/s43856-026-02000-y
UR - https://www.nature.com/articles/s43856-026-02000-y
AB - Background: Type 2 inflammatory diseases (T2IDs) such as atopic dermatitis (AD), asthma, food allergy, eosinophilic esophagitis (EoE), chronic sinusitis (CS), and others, are immune-mediated conditions that frequently co-occur across organ systems and contribute to substantial disease burden. While the atopic march has long served as a conceptual model for T2ID progression, it remains unclear whether this linear sequence captures the broader comorbidity structure of T2IDs. Methods: We systematically analyzed comorbidity patterns across nine T2IDs using two complementary methods: Large-scale real-world data (RWD) from over 129 million electronic health records, genome-wide and local genetic correlation, including three novel (asthma, chronic sinusitis, allergic rhinitis) metanalyses of genome-wide association studies. Results: Retrospective matched cohort analyses reveal a highly interconnected disease network in which CS emerged as a central node, increasing the risk of multiple other T2IDs across diverse patient populations. AD, food allergy, and vasomotor and allergic rhinitis also show strong cross-disease effects. Subgroup analyses uncover notable age-, sex-, and race-specific disparities. Genetic correlation analyses support shared heritability among many disease pairs, complemented by the temporal ordering of associations present in the RWD. Local genetic correlation position asthma as the central node of the shared polygenic architecture, converging on canonical type 2 inflammatory loci. Conclusions: Together, our results highlight that T2ID progression extends beyond the atopic march and is shaped by a complex and heterogeneous network of interactions. This work provides a data-driven framework to guide risk stratification, inform early preventive strategies, and prioritize upstream disease targets within the type 2 inflammatory spectrum.
SN - 2730-664X
ER -